These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10354036)

  • 21. Pityriasis rubra pilaris and HIV infection: a part of the spectrum of HIV-associated follicular syndrome.
    Sánchez-Regaña M; Fuentes CG; Creus L; Salleras M; Umbert P
    Br J Dermatol; 1995 Nov; 133(5):818-9. PubMed ID: 8555047
    [No Abstract]   [Full Text] [Related]  

  • 22. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
    Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Horny perifollicular mucinosis. An atypical pityriasis rubra pilaris-like eruption associated with HIV infection.
    Perrin C; Durant JM; Lacour JP; Michiels JF; Dellamonica P; Ortonne JP
    Am J Dermatopathol; 1993 Aug; 15(4):358-62. PubMed ID: 8214392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pruritus by capsaicin in a patient with pityriasis rubra pilaris receiving RE-PUVA therapy.
    Neess CM; Hinrichs R; Dissemond J; Herrmann G; Poswig A; Servera-Llanras M; Hunzelmann N; Brenneisen P; Meewes C; Krieg T; Scharffetter-Kochanek K
    Clin Exp Dermatol; 2000 May; 25(3):209-11. PubMed ID: 10844497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS.
    Bonomo RA; Korman N; Nagashima-Whalen L; Briggs J; Graham R; Salata RA
    Am J Med Sci; 1997 Aug; 314(2):118-21. PubMed ID: 9258214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic sclerosis in a patient with pityriasis rubra pilaris.
    Frikha F; Frigui M; Masmoudi H; Turki H; Bahloul Z
    Pan Afr Med J; 2010 Aug; 6():6. PubMed ID: 21436949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoaggravated pityriasis rubra pilaris.
    Evangelou G; Murdoch SR; Palamaras I; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):272-4. PubMed ID: 16149942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
    Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
    Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration.
    Bürgisser P; Spertini F; Weyrich-Suter C; Pagani JL; Meylan PR
    J Infect Dis; 1997 May; 175(5):1202-5. PubMed ID: 9129086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
    Sehgal VN; Srivastava G; Verma P
    Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
    Lancet; 1997 May; 349(9063):1413-21. PubMed ID: 9164314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
    Matheron S; Descamps D; Boué F; Livrozet JM; Lafeuillade A; Aquilina C; Troisvallets D; Goetschel A; Brun-Vezinet F; Mamet JP; Thiaux C;
    Antivir Ther; 2003 Apr; 8(2):163-71. PubMed ID: 12741629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pityriasis rubra pilaris as the initial manifestation of leukemia.
    Reinhardt LA; Rosen T
    Cutis; 1983 Jan; 31(1):100-2. PubMed ID: 6825457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS.
    Chougnet C; Jankelevich S; Fowke K; Liewehr D; Steinberg SM; Mueller BU; Pizzo PA; Yarchoan R; Shearer GM
    J Infect Dis; 2001 Jul; 184(2):201-5. PubMed ID: 11424019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pityriasis rubra pilaris in a child seropositive for the human immunodeficiency virus.
    Menni S; Brancaleone W; Grimalt R
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1009. PubMed ID: 1479079
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
    Sáez-Llorens X; Nelson RP; Emmanuel P; Wiznia A; Mitchell C; Church JA; Sleasman J; Van Dyke R; Richardson CG; Cutrell A; Spreen W; Hetherington S
    Pediatrics; 2001 Jan; 107(1):E4. PubMed ID: 11134468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.
    Matsuda T; Yamazaki F; Ueda-Hayakawa I; Kambe N; Okamoto H
    J Dermatol; 2019 Jan; 46(1):70-72. PubMed ID: 30506728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
    Tanguilig GG; Rutzen AR; Ortega-Larrocea G
    Am J Ophthalmol; 1998 Apr; 125(4):567-8. PubMed ID: 9559752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.